Home / Companies / Shanghai RAAS Blood Products Co., Ltd. / 29 Jul 2024
Shanghai RAAS Blood Products Co., Ltd.: meeting of 29 Jul 2024
Votes reported on Form N-PX, item by item
30 Form N-PX filers reported votes at the Shanghai RAAS Blood Products Co., Ltd. meeting of 29 Jul 2024. Their records fall into 9 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
11 nominees; 81.5% of reported votes for; 7 filers withheld from or voted against at least one nominee.
135 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.
DIRECTOR ELECTIONSSecurity holder
Director elections (nominees put forward by security holders)
12 nominees; 70.0% of reported votes for; 23 filers withheld from or voted against at least one nominee.
564 vote records from 23 filers. No filer marked a management recommendation, so no against-management figure is reported. 23 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
8 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
22 vote records from 6 filers. 0 of the 6 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
58 vote records from 29 filers. 0 of the 29 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
47 vote records from 23 filers. 0 of the 23 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
153 vote records from 26 filers. 0 of the 26 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
24 vote records from 4 filers. No filer marked a management recommendation, so no against-management figure is reported. 4 filers reported this item without a management mark.
AUDIT-RELATEDSecurity holder
Shareholder proposal: AUDIT-RELATED
47 vote records from 23 filers. 0 of the 23 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Directors | 3. Auditor | 9. Proposal |
|---|---|---|---|---|
| Vanguard | No report | For | No report | For |
| BlackRock and iShares | For | No report | No report | No report |
| Fidelity | No report | For | No report | For |
| Dimensional | No report | For | No report | For |
| State Street and SPDR | No report | For | No report | For |
| Franklin Templeton | No report | For | No report | For |
| Charles Schwab | For | No report | No report | No report |
| Nuveen and TIAA | No report | Abstain or withhold | No report | For |
| John Hancock and Manulife | For | No report | For | No report |
| Morgan Stanley, Eaton Vance and Calvert | No report | For | No report | For |
| WisdomTree | No report | For | No report | For |
| Jackson National funds | For | No report | For | No report |
| Northern Trust and FlexShares | No report | For | No report | For |
| Lincoln Financial | No report | For | No report | For |
| Voya | No report | For | No report | For |
| BNY Mellon | No report | For | No report | For |
| Pacific Life funds | No report | For | No report | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Shanghai RAAS Blood Products Co., Ltd. meeting?
30 Form N-PX filers reported votes at the meeting of 29 Jul 2024. One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Shanghai RAAS Blood Products Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Shanghai RAAS Blood Products Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Shanghai RAAS Blood Products Co., Ltd. with a meeting date within three days of 29 Jul 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.